Siliq (Brodalumab)

**Product type:** Human Prescription Drug

**Active ingredient:** BRODALUMAB

**Strength:** 210 mg/1

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Bausch Health US LLC

**Marketing category:** BLA (BLA761032)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Interleukin 17 Receptor A Antagonists [MoA], Interleukin-17 Receptor A Antagonist [EPC]